Skip to main content
. 2015 Sep 22;10(9):e0137885. doi: 10.1371/journal.pone.0137885

Fig 1. Kaplan—Meier survival curves for ypTNM stage, RCB, RDBN, TRR, Sataloff's T classification, and Miller-Payne grade showing disease-free survival rates for patients with HR+/HER2- breast cancer treated with anthracycline with/without taxane-based neoadjuvant chemotherapy.

Fig 1

Three evaluation systems assessing the absolute residual tumor, ypTNM stage, RCB, and RDBN, have prognostic significance. (RCB, residual cancer burden; RDBN, residual disease in breast and node; TRR, tumor response ratio).